Clinical application of thioredoxin reductase as a novel biomarker in liver cancer
Abstract Hepatic cancer is often amenable to surgery, including percutaneous ablation, trans-arterial chemoembolization. However, in metastatic cases, surgery is often not an effective option. Chemotherapy as a conventional clinical method for treatment of malignant diseases may be useful in such ca...
Guardado en:
Autores principales: | Xuping Wu, Qi Wang, Yousheng Lu, Jinye Zhang, Hanwei Yin, Yongxiang Yi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea2342db5ee242668d9b3e5263a5e4c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death
por: Shibo Sun, et al.
Publicado: (2021) -
Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.
por: Karin Anestål, et al.
Publicado: (2008) -
Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.
por: Catherine Méplan, et al.
Publicado: (2012) -
Sulforaphane-induced transcription of thioredoxin reductase in lens: possible significance against cataract formation
por: Varma SD, et al.
Publicado: (2013) -
Yeast thioredoxin reductase Trr1p controls TORC1-regulated processes
por: Cecilia Picazo, et al.
Publicado: (2018)